StonvexLoading…
StonvexStonvexStonvexCore line items from NGVT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.17B | $1.20B | $1.22B | $1.67B |
Operating Income | $418.70M | $425.90M | $423.20M | $452.60M |
Net Income | $-167.10M | $-430.30M | $-5.40M | $211.60M |
EPS (Diluted) | $-4.61 | $-11.85 | $-0.15 | $5.50 |
Total Assets | $1.65B | $2.02B | $2.62B | $2.74B |
Total Liabilities | $1.62B | $1.83B | $1.99B | $2.04B |
Cash & Equivalents | $78.10M | $68.00M | $95.90M | $76.70M |
Free Cash Flow OCF − CapEx | $273.50M | $51.00M | $95.30M | $170.90M |
Shares Outstanding | 35.49M | 36.35M | 36.23M | 37.30M |